Price Chart

Profile

Cassava Sciences Inc is a clinical-stage biotechnology company engaged in developing a scientific approach for the treatment and detection of Alzheimer's disease. Its therapeutic product candidate is called simufilam, and it is a novel treatment for Alzheimer's disease; and investigational diagnostic product candidate is called SavaDx, and it is a novel way to detect the presence of Alzheimer's disease from a small sample of blood, possibly years before the overt appearance of clinical symptoms.
URL https://www.cassavasciences.com
Investor Relations URL http://investor.paintrials.com/
HQ State/Province Texas
Sector Healthcare
Industry Biotechnology
Equity Style Small Cap/Growth
Next Earnings Release Feb. 28, 2024 (est.)
Last Earnings Release Nov. 07, 2023
Next Ex-Dividend Date N/A
Last Ex-Dividend Date Dec. 13, 2012

Profile

Cassava Sciences Inc is a clinical-stage biotechnology company engaged in developing a scientific approach for the treatment and detection of Alzheimer's disease. Its therapeutic product candidate is called simufilam, and it is a novel treatment for Alzheimer's disease; and investigational diagnostic product candidate is called SavaDx, and it is a novel way to detect the presence of Alzheimer's disease from a small sample of blood, possibly years before the overt appearance of clinical symptoms.
URL https://www.cassavasciences.com
Investor Relations URL http://investor.paintrials.com/
HQ State/Province Texas
Sector Healthcare
Industry Biotechnology
Equity Style Small Cap/Growth
Next Earnings Release Feb. 28, 2024 (est.)
Last Earnings Release Nov. 07, 2023
Next Ex-Dividend Date N/A
Last Ex-Dividend Date Dec. 13, 2012